Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RELA | Q04206 | 3/20 | 0.61 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.50 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | FGF23 | Q9GZV9 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14003996 | 1.00 | RELA (0.61) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL237049 | 1.00 | RELA (0.61) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL10434435 | 1.00 | RELA (0.61) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL18418097 | 1.00 | RELA (0.61) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL18418089 | 1.00 | RELA (0.61) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL237048 | 1.00 | RELA (0.61) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL14265605 | 0.98 | RELA (0.59) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL5488600 | 0.98 | RELA (0.59) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL5488602 | 0.98 | RELA (0.59) | RELATRPM8CTDSP1NFE2L2HPGD | |
| SCHEMBL14003818 | 0.96 | RELA (0.55) | RELATRPM8CTDSP1NFE2L2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1074601-B1 | Organic electroluminescent material and electroluminescent device using the same | SAMSUNG DISPLAY CO LTD (KR) | 2014-11-05 | — | — | EP | disclosed |
| US-7201976-B2 | Organic electroluminescence material and electroluminescence device using the same | SAMSUNG SDI CO., LTD. (KR) | 2007-04-10 | — | — | US | disclosed |
| US-20060263639-A1 | ORGANIC ELECTROLUMINESCENCE MATERIAL AND ELECTROLUMINESCENCE DEVICE USING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2006-11-23 | — | — | US | disclosed |
| US-20040018387-A1 | Organic electroluminescence material and electroluminescence device using the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2004-01-29 | — | — | US | disclosed |
| EP-1074601-A2 | Organic electroluminescent material and electroluminescent device using the same | NEC CORPORATION (JP) | 2001-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060263639-A1 | ORGANIC ELECTROLUMINESCENCE MATERIAL AND ELECTROLUMINESCENCE DEVICE USING THE SAME | ELAVL1, L1CAM, ELOB | RELA 2116/4885TRPM8 2694/4885CTDSP1 4612/4885 |
| US-20040018387-A1 | Organic electroluminescence material and electroluminescence device using the same | LEF1, ELAVL1, ELP1 | RELA 2573/4885TRPM8 3020/4885CTDSP1 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.